BioMarin to Acquire Amicus Therapeutics for $4.8 Billion — A Strategic Push to Tighten Rare‑Disease Leadership
BioMarin Pharmaceutical has agreed to acquire Amicus Therapeutics in an all‑cash deal valued at approximately $4.8 billion
Day: December 19, 2025
TikTok Signs Deal to Hand U.S. Operations to Oracle‑Led Investor Group — What the Split Means for Data, Regulation and Deals in 2026
TikTok has signed an agreement to transfer control of its U.S. operations to an investor consortium led by Oracle and including private equity and sovereign-backed investors, a move that aims to...
MUFG Bets $4.4 Billion on Shriram Finance as Japan’s Banks Double Down on India
Mitsubishi UFJ Financial Group (MUFG) agreed to buy a 20% stake in Shriram Finance for roughly INR 396.2 billion (about $4.4 billion), marking one of the largest foreign direct investments into...
Thoma Bravo’s Hypergene to Merge with Verdane‑backed Stratsys — Nordic SaaS Consolidation Accelerates
Thoma Bravo‑owned Hypergene and Verdane‑backed Stratsys have agreed to merge, creating an integrated Nordic provider that combines financial planning & analysis (FP&A) and portfolio management...
Piramal Finance to Sell Entire 14.72% Holding in Shriram Life Insurance to Sanlam EM for ₹600 Crore
Piramal Finance has agreed to sell its entire 14.72% stake in Shriram Life Insurance Company Ltd. (SLIC) to Sanlam Emerging Markets (Mauritius) for ₹600 crore, a transaction expected to close in...
Blackstone and Revolut Hold Initial Talks on Wealth Management Partnership
Blackstone and UK fintech Revolut have held preliminary discussions about a potential collaboration to expand wealth-management offerings, according to reporting that first appeared in Bloomberg and...
Standard General’s Soo Kim Holds Talks Over Possible Investment in Warner Bros. Discovery’s Cable Network Assets
Soo Kim, founder of New York hedge fund Standard General, has held discussions about acquiring or investing in Warner Bros. Discovery’s cable television assets — a package that would include...
Matt Holt Exits New Mountain Capital to Launch $30 Billion Health-Tech Carve-Out: A New Era for **Private Equity Portfolio Roll-Ups**
New Mountain Capital managing director Matt Holt is departing the firm to acquire five of its portfolio companies in a transaction valued at over $30 billion, marking one of the largest **private...